Compositions and methods of use of interleukin-10 peptides and anti-interleukin-10 antibodies
US-2016280778-A1 · Sep 29, 2016 · US
US9821029B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9821029-B2 |
| Application number | US-201514801160-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 16, 2015 |
| Priority date | Aug 2, 2013 |
| Publication date | Nov 21, 2017 |
| Grant date | Nov 21, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are methods of reducing Salmonella in the intestines of poultry in need thereof by administering to a poultry bird an effective amount of an interleukin-10 peptide or an isolated antibody that specifically binds an interleukin-10 peptide. Administering may be performed within 1 to 4 weeks of harvest of the poultry in order to reduce Salmonella transmission to human consumers. Also included herein are finishing feeds that include an interleukin-10 peptide or an isolated antibody that specifically binds an interleukin-10 peptide.
Opening claim text (preview).
The invention claimed is: 1. A method of reducing Salmonella in the intestines of poultry in need thereof, comprising administering to a poultry bird an effective amount of an isolated antibody that specifically binds an interleukin-10 peptide, wherein administering is within 1 to 4 weeks of harvest of the poultry, wherein the interleukin-10 peptide is SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5. 2. The method of claim 1 , wherein the poultry bird is a Salmonella incubatory or convalescent carrier. 3. The method of claim 1 , wherein the isolated antibody specifically binds SEQ ID NO: 2, or SEQ ID NO: 3. 4. The method of claim 1 , wherein the poultry is a chicken, a turkey, a duck, a quail, or a pheasant. 5. The method of claim 1 , wherein the poultry is a chicken, and wherein the isolated antibody that specifically binds the interleukin-10 peptide is administered at weeks 3, 4, 5, 6, 7, and/or 8 after hatch. 6. The method of claim 1 , wherein the poultry is a turkey, and wherein the isolated antibody that specifically binds the interleukin-10 peptide is administered at weeks 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 and/or 22 after hatch. 7. The method of claim 1 , wherein the isolated antibody is administered by injection or oral administration. 8. The method of claim 1 , wherein the isolated antibody is in the form of an avian egg yolk antibody. 9. The method of claim 8 , wherein the isolated antibody specifically binds SEQ ID NO: 2, or SEQ ID NO: 3. 10. The method of claim 1 , wherein the isolated antibody is administered in the form of a poultry feed composition. 11. The method of claim 10 , wherein the poultry feed composition is a finishing feed comprising no added antibiotics. 12. The method of claim 10 , wherein the isolated antibody is present in the poultry feed composition in an amount of 0.15 mg/kg of animal feed to 100 mg/kg of poultry feed.
isolated from eggs · CPC title
Antibiotics · CPC title
against proteinaceous materials, e.g. enzymes, hormones, lymphokines · CPC title
comprising antibodies · CPC title
oral/gastrointestinal · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.